- 1
First Quarterly | MAY 2019: ISSUE 1
Welcome to SynergEyes® Quarterly!
It is with great pleasure and pride that I am introducing our first quarterly newsletter to you, our team of distributors!
It has been a challenging project but you can now enjoy learning at your own pace and leisure: the SynergEyes® E-trainings!
During the last couple of years, the team consisting of Tina Sharp and Dede Reyes visited many conferences and introduced SynergEyes® Hybrid lenses to many practitioners. The explanations provided to the practitioners, often in the form of powerpoint presentations are now available in the form of the SynergEyes® E-training modules.
The SynergEyes, Inc. Board of Directors appointed Bob Ferrigno as Chief Executive Officer, effective June 27, 2018. Ferrigno joined SynergEyes in 2015, bringing a wealth of experience and expertise in the Health Care, Optometry, Medical Device, and Diagnostic Industries.
In April 18 Optician Awards 2019 were presented to UK Opticians, Contact Lens Practitioners and Manufacturers & Suppliers to the Optical Industry.
In all 18 trophies were presented at a 1980s themed glittering black tie bash in the Hilton Metropole next to the National Exhibition Centre near Birmingham coinciding with the Optrafair weekend.
The Winner of the Contact Lens Product of the Year was Duette by SynergEyes UK!
In Eyes Magazine March 2019, Phil Thomson, points out the importance of UV protecting Contact Lenses
In an interesting article in March UK Optical Magazine Eyes on page 18, Phil Thomson, Head of Professional Services SynergEyes.
Purpose
The case study describes the efficacy of a new design of hybrid contact lens for orthokeratology for reduction of both myopic and high astigmatic refractive errors.
In november 2015 Texas Eye Research & Technology Center TERTC investigated tear exchange under UltraHealth lenses in 17 existing contact lens wearers (8 females and 7 males, in age between 24 and 58 years) who were diagnosed with keratoconus. Aim of the study was to assess if tear ventilation in a hybrid modality (SynergEyes) provides tear exchange at sufficient levels to mimic soft or GP contact lenses. It is also suspected that this tear exchange will be enhanced over traditional scleral lens designs.
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to our Terms and Conditions. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by SynergEyes.